Evidence map›Paper›PMID 38280230›Full record

ReviewHuman molecular genetics2024

Mitochondrial protein synthesis quality control.

Lidiia Koludarova, Brendan J Battersby

Abstract readReview
In one paragraph

Review in Human molecular genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Complete Mitogenome sequencing of the fish louseFrontiers in veterinary science · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lidiia KoludarovaInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki 00014, Finland.
Brendan J BattersbyInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki 00014, Finland.ORCID 0000-0002-8136-2753

Funding

Hereditary Neuropathy Foundation and Lindsey FlyntHereditary Neuropathy Foundation and Lindsey Flynt, National Ataxia Foundation, and the Magnus Ehrnrooth FoundationMagnus Ehrnrooth FoundationNational Ataxia FoundationResearch Council of FinlandSigrid Juselius Foundation Senior Investigator AwardSigrid Juselius Foundation Senior Investigator Award, Research Council of Finland
6 · The paper itself

Abstract

Human mitochondrial DNA is one of the most simplified cellular genomes and facilitates compartmentalized gene expression. Within the organelle, there is no physical barrier to separate transcription and translation, nor is there evidence that quality control surveillance pathways are active to prevent translation on faulty mRNA transcripts. Mitochondrial ribosomes synthesize 13 hydrophobic proteins that require co-translational insertion into the inner membrane of the organelle. To maintain the integrity of the inner membrane, which is essential for organelle function, requires responsive quality control mechanisms to recognize aberrations in protein synthesis. In this review, we explore how defects in mitochondrial protein synthesis can arise due to the culmination of inherent mistakes that occur throughout the steps of gene expression. In turn, we examine the stepwise series of quality control processes that are needed to eliminate any mistakes that would perturb organelle homeostasis. We aim to provide an integrated view on the quality control mechanisms of mitochondrial protein synthesis and to identify promising avenues for future research.

Indexed as

MitochondriaMitochondrial ProteinsProtein BiosynthesisAnimalsDNA, MitochondrialHumansMitochondrial RibosomesRNA, MessengerDNA, MitochondrialMitochondrial ProteinsRNA, MessengerAFG3L2cell stressco-translational quality controlfusion open reading framesmembrane morphologymitochondriaMTRFRnon-stop mRNAOMA1OPA1OXA1Lpost-transcriptionalprotein synthesisproteostasisribosome quality controlribosomesRNA processing

Identifiers

PMID38280230
PMCPMC11112378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.